# EDGAR Filing Document

**Accession Number:** 0001463361
**File Stem:** 0001193125-25-220778
**Filing Date:** 2025-9
**Character Count:** 49192
**Document Hash:** 1fda3c9a0d9de815db120c3ec4d111dd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-220778.hdr.sgml**: 20250926

**ACCESSION NUMBER**: 0001193125-25-220778

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250924

**ITEM INFORMATION**: Termination of a Material Definitive Agreement

**ITEM INFORMATION**: Material Modifications to Rights of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250926

**DATE AS OF CHANGE**: 20250926

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Unity Biotechnology, Inc.
- **CENTRAL INDEX KEY:** 0001463361
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 264726035
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38470
- **FILM NUMBER:** 251351353

**BUSINESS ADDRESS:**
- **STREET 1:** 285 EAST GRAND AVENUE
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** (650) 416-1192

**MAIL ADDRESS:**
- **STREET 1:** 285 EAST GRAND AVENUE
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cenexys, Inc.
- **DATE OF NAME CHANGE:** 20130703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Forge Inc
- **DATE OF NAME CHANGE:** 20090504

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): September 24, 2025

## UNITY BIOTECHNOLOGY, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38470** | **26-4726035** |
| **(State or other jurisdiction**<br>**of incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification Number)** |

---

#### 124 Washington Street, Suite 101

#### Foxborough, Massachusetts 02035

#### (Address of principal executive offices, including Zip Code)

#### Registrant's telephone number, including area code: (508) 543-1720
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** |
| Common Stock, par value $0.0001 per share | \* |

---

\* As reported in the registrant's Current Report on Form 8-K filed on June 30, 2025, the registrant's common stock was suspended from trading on The Nasdaq Stock Market LLC ("Nasdaq") on July 9, 2025. On August 6, 2025, Nasdaq filed a Form 25 with the Securities and Exchange Commission (the "SEC") to delist the shares of common stock, $0.0001 par value per share, of the registrant. The delisting became effective on August 16, 2025. The deregistration of the shares of common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), will be effective 90 days, or such shorter period as the SEC may determine, after the filing date of the Form 25.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 1.02** | **Termination of a Material Definitive Agreement.** |

---

On September 24, 2025, Unity Biotechnology, Inc. (the "Company") entered into a Lease Termination Agreement and Amendment (the "Lease Termination Agreement") with Bayside Area Development, LLC, a Delaware limited liability company (the "Landlord"), pursuant to which the Company and Landlord agreed to terminate that certain Lease, dated February 29, 2019, as amended (the "Original Lease"), related to the Company's office and laboratory space located at 285 E. Grand Avenue, South San Francisco, CA 94080. Prior to the Lease Termination Agreement, the term of the Original Lease was set to expire on December 31, 2029. Pursuant to the Lease Termination Agreement, the Original Lease will be terminated effective as of 11:59 p.m. on March 31, 2026 (the "Early Termination Date"), provided, that, Landlord has the right, at Landlord's option, upon at least thirty (30) days' prior written notice to the Company, to accelerate and designate an earlier Early Termination Date. As consideration for the Lease Termination Agreement, the Company agreed to pay Landlord approximately $3.65 million as prepaid rent in fulfillment of its rent obligations, consisting of $2.75 million paid by the Company concurrently with the execution of the Lease Termination Agreement and a right to draw down a letter of credit issued in the face amount of $0.90 million.

Additionally, in connection with the termination of the Original Lease, the Company entered into a Sublease Termination Agreement (the "Sublease Termination Agreement") with Initial Therapeutics, Inc., a Delaware corporation (the "Subtenant"), pursuant to which the Company and the Subtenant agreed to terminate that certain Sublease, dated May 24, 2022, as amended by the First Amendment to Sublease, dated September 14, 2023, related to the Company's sublease of office and laboratory space located at 285 E. Grand Avenue, South San Francisco, CA 94080, to the Subtenant. As consideration for the Sublease Termination Agreement, Subtenant paid the Company $0.20 million concurrently with execution of the Sublease Termination Agreement, which the Company is obligated to pay to Landlord within 10 days of receipt pursuant to the Lease Termination Agreement, and granted the Company the right to draw down a letter of credit in the face amount of $0.73 million, which the Company is obligated to draw down and pay the proceeds to Landlord pursuant to the Lease Termination Agreement, provided that, if the Company is unable to draw any such proceeds, the Company's agreement with Landlord will be unaffected.

Further, pursuant to the Lease Termination Agreement, in the event that the Company receives any cash consideration from the monetization, including through the issuance of equity or other securities, of the Company's corporate assets, within the period of September 24, 2025 through twenty-four (24) months following the Early Termination Date, Landlord is entitled to receive an amount equal to 25% of the value of such cash consideration up to a total aggregate amount of $26.9 million, which aggregate cap shall be reduced by an amount equal to the sum of prepaid rent received by Landlord. Such amount is to be paid by the Company to Landlord in cash within 30 days after the consummation of any such transaction.

As previously disclosed, in May 2025, the Company implemented a plan to reduce operating costs and preserve capital following the disclosure of full 36-week data from the Company's ASPIRE study, which included a reduction in force affecting all of the Company's employees. Further, in June 2025, the Company announced that the Board of Directors of the Company (the "Board") determined that it is in the best interests of the Company and its stockholders that the Company be dissolved, approved the voluntary dissolution of the Company (the "Dissolution") under the General Corporation Law of the State of Delaware (the "DGCL") pursuant to a Plan of Complete Liquidation and Dissolution (the "Plan of Dissolution"), and approved seeking stockholder approval to proceed with such dissolution. In light of such actions, the Company determined to terminate its lease.

The foregoing summary of the Lease Termination Agreement does not purport to be complete and is qualified in its entirety by the full text of the Lease Termination Agreement, a copy of which is filed herewith as Exhibit 10.1.

---

| | |
|:---|:---|
| **Item 3.03** | **Material Modification to Rights of Security Holders.** |

---

As previously reported, on June 27, 2025, the Board approved the Dissolution under the DGCL pursuant to the Plan of Dissolution. The Company's stockholders approved the Dissolution and Plan of Dissolution on September 18, 2025.

On September 26, 2025, as contemplated by the Plan of Dissolution, the Company filed a certificate of dissolution (the "Certificate of Dissolution") with the Secretary of the State of Delaware, which became effective as of 5:00 p.m. Eastern Time on September 26, 2025. For additional information regarding the Plan of Dissolution and the Dissolution, refer to the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on August 11, 2025.

Pursuant to and in accordance with the Plan of Dissolution, as of September 26, 2025, the Company has closed its transfer books, and shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), will no longer be assignable or transferable on the Company's books, other than transfers by will, intestate succession, operation of law or upon dissolution of such record holder or its successors. In addition, from and after the effectiveness of the Certificate of Dissolution, the Company's stockholders shall have only such rights and obligations as are provided for under the DGCL for stockholders of a dissolved corporation.

------

A copy of the Certificate of Dissolution is filed herewith as Exhibit 4.1 and is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit<br>No.** | **Description** |
| 4.1 | [Certificate of Dissolution as filed by Unity Biotechnology, Inc. with the Secretary of the State of Delaware, effective September 26, 2025](d190494dex41.htm) |
| 10.1\* | [Lease Termination Agreement and Amendment, by and between Unity Biotechnology, Inc. and Bayside Area Development, LLC, dated September 24, 2025](d190494dex101.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **UNITY BIOTECHNOLOGY, INC.** | **UNITY BIOTECHNOLOGY, INC.** |
| Date: September 26, 2025 | By: | /s/ Craig Jalbert |
|  |  | Craig Jalbert |
|  |  | President |

---

## Exhibit 4.1

**Exhibit 4.1** 

**CERTIFICATE OF DISSOLUTION OF** 

**UNITY BIOTECHNOLOGY, INC.** 

Pursuant to Section 275(a) and (b)

of the General Corporation Law of the State of Delaware

Unity Biotechnology, Inc. (the "<u>Corporation</u>"), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "<u>General Corporation Law</u>"), DOES HEREBY CERTIFY:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The name of the Corporation is Unity Biotechnology, Inc.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The date the dissolution was authorized is September 18, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The dissolution of the Corporation was duly authorized by the Board of Directors and the stockholders of the Corporation in accordance with the provisions of Section 275(a) and (b) of the General Corporation Law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The names and addresses of the directors and officers of the Corporation are as follows:

**<u>DIRECTORS</u>**

Craig Jalbert c/o Unity Biotechnology, Inc. 124 Washington Street, Suite 101 Foxborough, Massachusetts 02035

**<u>OFFICERS</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Craig Jalbert President & Secretary c/o Unity Biotechnology, Inc. 124 Washington Street, Suite 101 Foxborough, Massachusetts 02035

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The date of filing of the Corporation's original certificate of incorporation with the Secretary of State of the State of Delaware is March 30, 2009.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. This certificate of dissolution shall be effective as of 5:00 p.m. Eastern Time on September 26, 2025.

[*Signature Page Follows*]

------

IN WITNESS WHEREOF, the Corporation has caused this Certificate to be duly executed this <u>26th</u> day of September, 2025.

---

| |
|:---|
| **UNITY BIOTECHNOLOGY, INC.** |
| By: /s/ Craig Jalbert |
| Name: Craig Jalbert |
| Title: President |

---

## Exhibit 10.1

**Exhibit 10.1** 

**<u>LEASE TERMINATION AGREEMENT</u>**

**<u>AND AMENDMENT</u>**

This LEASE TERMINATION AGREEMENT AND AMENDMENT (this "**Agreement**") is entered into as of September 24, 2025 (the "**Effective Date**") by and between BAYSIDE AREA DEVELOPMENT, LLC, a Delaware limited liability company ("**Landlord**"), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation ("**Tenant**").

<u>R</u> <u>E</u> <u>C</u> <u>I</u> <u>T</u> <u>A</u> <u>L</u> <u>S</u> :

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Landlord and Tenant are parties to the Lease dated February 29, 2019 (the "**Lease**"), whereby Tenant currently leases approximately 62,655 rentable square feet of space (the "**Premises**") comprising the entire rentable area of the building located at 285 E. Grand Avenue, South San Francisco, CA 94080 (the "**Building**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. As of the Effective Date, Initial Therapeutics, Inc., a Delaware corporation ("**Subtenant**") currently subleases a portion of the Premises (the "**Sublet Premises**", as more particularly set forth therein) from Tenant (as sublandlord) pursuant to that certain Sublease dated May 24, 2022 (the "**Original Sublease**") between Subtenant and Tenant (as sublandlord), as amended by that certain First Amendment to Sublease dated September 14, 2023 (the "**Sublease First Amendment**") between Tenant and Subtenant. The Original Sublease and the Sublease First Amendment are collectively referred to as the "**Existing Sublease**". Landlord consented to the Existing Sublease pursuant to that certain Consent to Sublease Agreement dated June 29, 2022 by and among Landlord, Tenant and Subtenant, as amended by that certain First Amendment to Consent to Sublease Agreement dated September 26, 2023 by and among Landlord, Tenant and Subtenant (collectively, the "**Existing Consent to Sublease**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. As of the Effective Date, Nine Square Therapeutics Corporation, Inc., a Delaware corporation ("**Sub-Subtenant**") currently sub-subleases a portion of the Premises (the "**Sub-Sublet Premises**", as more particularly set forth therein) from Subtenant (as sub-sublandlord) pursuant to that certain Sub-Sublease dated May 24, 2022 (the "**Original Sub-Sublease**") between Sub-Subtenant and Subtenant (as sub-sublandlord), as amended by that certain First Amendment to Sub-Sublease dated September 14, 2023 (the "**Sub-Sublease First Amendment**") between Subtenant and Sub-Subtenant. The Original Sub-Sublease and the Sub-Sublease First Amendment are collectively referred to as the "**Existing Sub-Sublease**". Landlord consented to the Existing Sub-Sublease pursuant to that certain Consent to Sub-Sublease Agreement dated June 30, 2022 by and among Landlord, Tenant, Subtenant and Sub-Subtenant, as amended by that certain First Amendment to Consent to Sub-Sublease Agreement dated September 26, 2023 by and among Landlord, Tenant, Subtenant and Sub-Subtenant (collectively, the "**Existing Consent to Sub-Sublease**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D. Tenant and Landlord desire to enter into this Agreement in order to (i) terminate the Lease and provide for Tenant's release of Landlord as provided herein; and (ii) amend certain provisions of the Lease, all as hereinafter provided. Each capitalized term when used herein shall have the same respective meaning as is given such term in the Lease, Existing Sublease or Existing Sub-Sublease, as applicable, unless expressly provided otherwise in this Agreement.

<u>A</u> <u>G</u> <u>R</u> <u>E</u> <u>E</u> <u>M</u> <u>E</u> <u>N</u> <u>T</u> :

NOW, THEREFORE, in consideration of the foregoing recitals and the conditions and the covenants hereinafter contained, and for other consideration hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>Termination of the Lease</u>**. The Lease Term for the Lease is currently scheduled to expire on December 31, 2029 (the "**Original Expiration Date**"). Notwithstanding the foregoing, the Lease shall terminate and be of no further force or effect as of 11:59 P.M. on **March 31, 2026** ("**Termination Date**"); provided, that, notwithstanding anything in this Agreement to the contrary, following the mutual execution and delivery of this Agreement, Landlord shall have the right, at Landlord's option, upon at least thirty (30) days' prior written notice to Tenant, to accelerate and designate an earlier Termination Date under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>Obligation to Pay Rent</u>**. From the Effective Date of this Agreement through and including the Termination Date, Tenant shall remain obligated for and shall continue to pay Base Rent, Tenant's Share of Direct Expenses and all other amounts of Additional Rent, if any, due to Landlord, per the terms of the Lease; provided, that, Tenant's full payment of the Prepaid Rent (as defined below) shall satisfy such obligations to pay Base Rent, Tenant's Share of Direct Expenses, and all other amounts of Additional Rent, if any, due to Landlord, for such period, including any period in arrears, as more particularly set forth in Section 4(a) below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>Surrender of Premises; Required Surrender Conditions; Elective Early Surrender</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **<u>Surrender of Premises; Required Surrender Conditions</u>**. Tenant hereby agrees to vacate the Premises and surrender and deliver exclusive possession thereof to Landlord on or before the Termination Date, which surrender shall be completed in accordance with the all applicable surrender provisions of the Lease (the "**Required Surrender Conditions**"), which Required Surrender Conditions, notwithstanding anything in the Lease, shall include, without limitation, the following: (i) causing the Existing Subtenant to vacate the Sublet Premises and the Existing Sub-Subtenant to vacate the Sub-Sublet Premises; and (ii) surrendering in accordance with the terms of <u>Article</u> <u>15</u> of the Lease, which shall include, without limitation, with respect to any laboratory areas of the Premises, decommissioning, receipt of written closure from the applicable governmental agencies as required by applicable laws and closing or transferring of any permits and licenses; provided, however, that Tenant's compliance with this Section 3(a) shall have been deemed complete on the date of the Company's certification to Landlord that the required inspectors have been to the Premises and inspected the Premises with no material issues such that a final certification is expected to issue (and in the event outstanding issues remain, Tenant shall be liable to Landlord for Base Rent, Additional Rent and all other amounts due to Landlord up to and including the date of such certification pursuant to the terms of the Lease).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **<u>Elective Early Surrender</u>**. Notwithstanding, and without modifying or accelerating the Termination Date, Tenant desires to vacate and abandon the Premises and cease conducting business operations therefrom for the remainder of the current Lease Term through and including such Termination Date. In connection therewith, the parties hereby acknowledge and agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i) following the Effective Date, Tenant shall be permitted to so vacate and abandon the Premises and cease conducting business operations therefrom, and any such vacation, abandonment and cessation of business operations by Tenant shall not be an Event of Default by Tenant under Section 19.1.3 of the Original Lease (and for purposes of clarification, the Lease shall otherwise remain in full force and effect [as amended by this Agreement] and the Termination Date shall still occur as set forth in Section 1 above);

ii) within three (3) business days of Tenant providing Landlord with written notice (the "**Early Surrender Notice**") that Tenant has so vacated and abandoned the Premises, which notice can be sent electronically, Landlord shall perform a walkthrough of the Premises to inspect the same in order to confirm satisfaction of the Required Surrender Conditions, and in connection therewith: (A) if Landlord confirms that Tenant has so vacated and surrendered and satisfied the Required Surrender Conditions, then Landlord shall promptly provide written notice to Tenant (the "**Early Surrender Confirmation Notice**") confirming the same, which notice can be sent electronically (if, however, Landlord reasonably determines that the Required Surrender Conditions were not satisfied, then, in lieu thereof, Landlord shall provide written notice of the same to Tenant, which notice can be sent electronically, together with a reasonable description of the applicable issues, in which event, upon correction, Tenant may again proceed with delivering a new Early Surrender Notice to Landlord hereunder); (B) from and after the date that Tenant receive the Early Surrender Confirmation Notice from Landlord (the "**Early Surrender Confirmation Date**"), so long as Tenant or any of its agents, employees, contractors, licensees or invitees do not access the Premises and/or Project thereafter, the parties hereby acknowledge and agree as follows:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Tenant shall have no obligation to perform Tenant's Repair Obligations as defined and set forth in Section 7.1 of the Original Lease (including, without limitation, no obligation to maintain any of the Service Contracts defined and set forth in Section 7.2 of the Original Lease), and in connection therewith, Landlord shall have no obligation to perform Landlord's Repair Obligations as defined and set forth in Section 7.4 of the Original Lease);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Tenant shall not be obligated to carry the policies of Tenant insurance coverage set forth in Section 10.3 of the Original Lease (provided, however, if Tenant or any of its agents, employees, contractors, licensees or invitees desire to access the Premises after the Early Surrender Confirmation Date, then Tenant shall again be required to carry all insurance coverage required of Tenant under the Lease for such dates and periods of access [and provide evidence of the same to Landlord]);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) with respect to Section 10.1 of the Original Lease, Tenant shall have no obligation to indemnify Landlord with respect to any claims, loss, cost, damage, injury, expense and liability with or arising from "*any cause in, on or about the Premises*" (provided, that, Tenant's other indemnification obligations that expressly survive the termination of the Lease shall remain in force and effect, subject, however, to the terms and conditions of this Agreement, including without limitation, Sections 5, 6 and 7 below); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Neither Landlord nor Tenant shall have any obligation to perform any restoration work under the Lease (as hereby amended) as a result of any such damage, destruction, condemnation or taking under Articles 11 and/or 13 of the Original Lease, as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>Consideration to Landlord; Prepaid Rent; Bill of Sale</u>**. In consideration for Landlord's execution of this Agreement, and as a condition to the effectiveness of this Agreement, Landlord and Tenant hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Notwithstanding anything in the Lease to the contrary, concurrently with Tenant's execution and delivery of this Agreement, Tenant shall irrevocably and unconditionally pay to Landlord the amount of $3,646,000.72 (the "**Prepaid Rent**"), which Prepaid Rent shall constitute Tenant's irrevocable, absolute, and unconditional payment in advance of the Base Rent, Tenant's Share of Direct Expenses, and all other amounts of Additional Rent, if any, due to Landlord due under the Lease during the period of June 1, 2025 (retroactively applied) through and including the original Termination Date (the "**Prepaid Rent Period**"). Landlord and Tenant acknowledge and agree as follows: (A) concurrently with Tenant's execution and delivery of this Agreement, Tenant shall pay to Landlord a portion of the Prepaid Rent in the amount of $2,750,000.00 (the "**Prepaid Rent Payment**"); and (B) pursuant to Article 21 of the Original Lease, Landlord is the beneficiary under a letter of credit issued by Silicon Valley Bank (the "**Bank**") in the face amount of $896,000.72 (the "**Letter of Credit**") as protection for the full and faithful performance by Tenant of all of its obligations under this Lease, and in connection therewith: (1) as soon as is reasonably possible following Tenant's execution and delivery of this Agreement, and in satisfaction of Tenant's obligation to immediately pay the remainder of the Prepaid Rent in excess of the Prepaid Rent Payment, Landlord have the right to immediately draw down on the entirety of the Letter of Credit in accordance with the terms of the Lease, and apply the entirety of any proceeds of the Letter of Credit actually received by Landlord as further partial payment of the Prepaid Rent; (2) Tenant irrevocably and unconditionally waives any and all rights that it may have to object to or otherwise hinder Landlord's draw of the Letter of Credit under the Lease or applicable law; and (3) Tenant further agrees to fully cooperate with Landlord in connection with Landlord's draw on the Letter of Credit, and further agrees to execute any documents requested by either Landlord or the Bank in connection with any such draw. Notwithstanding anything in the Lease to the contrary, as a result of the application of the Prepaid Rent Payment and the proceeds of the Letter of Credit towards the payment of Prepaid Rent as provided herein, (a) the Prepaid Rent shall be deemed fully earned by Landlord upon application of the Prepaid Rent Payment and/or Letter of

------

Credit Proceeds, (b) the Prepaid Rent shall be a final and absolute payment to Landlord that is non-refundable to Tenant in all events (including, without limitation, if Landlord accelerates the Termination Date pursuant to Section 1 above), (c) Landlord shall have no obligation to return to Tenant any portion of either the Prepaid Rent Payment or the Letter of Credit proceeds applied by Landlord to the Prepaid Rent, (d) Tenant hereby forever and irrevocably relinquishes and releases any and all rights to the return of either the Prepaid Rent Payment, the Letter of Credit currently held by Landlord under the Lease, or any proceeds of the Letter of Credit, and (e) Tenant shall have no obligation to deliver to Landlord any replenishment of the L-C Amount (or replacement Letter of Credit) following such draw down of the same pursuant to hereinabove. Tenant further acknowledges and agrees that Tenant's obligation to pay the Prepaid Rent is fully and clearly set stated in this Agreement and Tenant waives the benefits and protections of Section 1950.8 of the California Civil Code. Tenant also unconditionally and irrevocably waives and releases any rights or claims Tenant may have under Section 1951.7 of the California Civil Code with respect to the Prepaid Rent Payment, the Letter of Credit, or the Letter of Credit proceeds, including without limitation, any right to request notice under Section 1951.7(c) or any other similar laws, statutes, or ordinances now or hereinafter in effect. If, for any reason, Landlord is unable or unwilling to draw on the Letter of Credit, in whole or in part, following the expiration of three (3) business days following Landlord's written notice to Tenant of such inability or failure (the "**Letter of Credit Draw Failure Notice**"), Tenant shall immediately pay to Landlord the full remaining amount of the Prepaid Rent (less the Prepaid Rent Payment and any proceeds of the Letter of Credit actually received by Landlord) by wire transfer of immediately available funds (the "**Alternative Cash Termination Payment**") and following Landlord's receipt of the full applicable Alternative Cash Termination Payment, Landlord shall not be entitled to and have no further rights in and to the Letter of Credit and/or any proceeds thereof to the extent resulting in any double recovery of the applicable underlying amounts. If Tenant falls to timely pay the Alternative Cash Termination Payment within three (3) business days after Tenant's receipt of the Letter of Credit Draw Failure Notice, then Landlord may declare a material and uncurable event of default under the Lease (without the requirement of any additional notice or cure periods as may be required by the terms of the Lease); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Tenant shall concurrently with the execution of this Agreement, deliver to Landlord an executed bill of sale (in the form of **<u>Exhibit A</u>** attached hereto), conveying the scope of existing furniture, fixtures and equipment, audio visual equipment, security, cabling and other items in the Premises as of the Effective Date referenced in the bill of sale to Landlord for the price of One Dollar ($1.00).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>Mutual Release of Parties from Liability</u>**. Except for any of Landlord's or Tenant's obligations, duties and rights under this Agreement, as the case may be, and except as otherwise provided in <u>Sections</u> <u>6</u> and <u>7</u> below, effective as of the Termination Date (or any earlier Early Surrender Confirmation Date [as the earlier alternative to the Termination Date], unless Tenant or any of its agents, employees, contractors, licensees or invitees access the Premises and/or Project thereafter, in which event such reference shall remain the Termination Date):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Landlord and Tenant (as the case may be) shall be fully and unconditionally released and discharged from its respective obligations arising from or connected with the provisions of the Lease (including with respect to the Premises), specifically including, without limitation, (1)_any right Tenant may have to audit or review Landlord's books or records or to contest any Direct Expenses, billed to Tenant under the Lease, and (2) any right of Landlord to be paid any Base Rent, Tenant's Share of Direct Expenses and/or any other Additional Rent; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement shall fully and finally settle all of Tenant's and Landlord's (as the case may be) demands, charges, claims, accounts or causes of action of any nature, including, without limitation, both known and unknown claims and causes of action that may arise out of or in connection with the obligations of Landlord or Tenant (as the case may be) under the Lease (and, as between Landlord and Tenant, only, the Existing Sublease and/or Existing Sub-Sublease).

------

Tenant and Landlord each expressly waives the provisions of California Civil Code Section 1542, which provides:

"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY."

Tenant and Landlord each acknowledges that it has received the advice of legal counsel with respect to the aforementioned waiver and understands the terms thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>Representations of Tenant</u>**. Tenant represents to Landlord that (a) as of the date hereof, except for the Existing Sublease and Existing Sub-Sublease, Tenant has not assigned or sublet all or any portion of its interest in the Lease or Premises; (b) no other person, firm or entity has any right, title or interest in the Lease; (c) Tenant has the full right, legal power and actual authority to enter into this Agreement and to terminate the Lease without the consent of any person, firm or entity; and (d) Tenant has the full right, legal power and actual authority to bind Tenant to the terms and conditions hereof. Tenant further represents to Landlord that as of the date hereof, to the best of its knowledge there are no, and as of the Termination Date there shall not be any, mechanic's liens or other liens encumbering all or any portion of the Premises, by virtue of any act or omission on the part of Tenant, its predecessors, contractors, agents, employees, successors or assigns. Notwithstanding the termination of the Lease and the release of liability provided for herein, the representations set forth in this <u>Section</u> <u>6</u> shall survive the Termination Date and Tenant shall be liable to Landlord for any inaccuracy or any breach thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>Continuing Liability</u>**. Notwithstanding the termination of the Lease and the release of liability provided for herein, except as expressly provided in this Agreement otherwise, Tenant and Landlord (as the case may be) shall each remain liable for: (i) with respect to the period of its tenancy prior to the Termination Date, (or any earlier Early Surrender Confirmation Date [as the earlier alternative to the Termination Date], unless Tenant or any of its agents, employees, contractors, licensees or invitees access the Premises and/or Project thereafter, in which event such reference shall remain the Termination Date), the performance of all of its respective obligations under the Lease and all of its respective obligations that otherwise expressly survive the termination of the Lease (provided, that, as more particularly set forth in Section 4(a) above, Landlord's receipt of the Prepaid Rent shall satisfy Tenant's financial obligations to pay Base Rent, Tenant's Share of Direct Expenses, and all other amounts of Additional Rent, if any, under the Lease); and (ii) Tenant's obligations under Sections 9 and 10 below. Landlord shall have all the rights and remedies with respect to such obligations as set forth in the Lease, including, without limitation, all rights and remedies at law and/or in equity with respect to Tenant's obligations under Section 8 below. In the event that Tenant (and/or Existing Subtenant and/or Existing Sub-Subtenant) retains possession of the Premises, or any part thereof, after the Termination Date, then the provisions of <u>Article</u> <u>16</u> of the Lease shall apply.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. **<u>New Corporate Consideration</u>**. As additional consideration to Landlord for entering into this Agreement, Tenant hereby acknowledges and agrees as follows: (i) in the event that Tenant (or Tenant's successor) receives any cash consideration (including, without limitation, capital infusions, loan proceeds and/or straight monetization of assets) from the monetization, including through the issuance of equity or other securities, of Tenant's corporate assets existing and owned as of the Effective Date (including intellectual property, licenses or any other assets reflected on the Tenant's balance sheet as of the Effective Date), within the period commencing on the Effective Date and continuing to and including the date that is twenty-four (24) months following the Termination Date, Landlord shall be entitled to receive an amount equal to twenty-five percent (25%) of the value of such cash consideration paid to or accruing to the shareholders of the Tenant as of the Effective Date as received by Tenant (but in no event in excess of a total aggregate amount of $26,875,959.00, which aggregate cap shall be reduced by an amount equal to the sum of any amounts of the Prepaid Rent received

------

by Landlord in accordance with Section 5(a) above), which amount shall be paid by Tenant to Landlord in cash within thirty (30) days after the consummation of any such transaction by Tenant; and (ii) in connection therewith: (A) Tenant shall provide Landlord with written notice of any such monetization event within ten (10) business days after the consummation of any such transaction by Tenant; and (B) upon request, Landlord shall have the right to review or audit supporting documentation reasonably necessary to verify proceeds and compliance with this Section 8 upon the execution of a commercially reasonable nondisclosure agreement. Notwithstanding anything in this Agreement, Tenant's obligations and Landlord's rights under this Section 8 shall survive the termination of the Lease under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>Existing Sublease L-C</u>**. Notwithstanding anything in the Lease, Existing Sublease and/or this Agreement, as between Landlord and Tenant, as additional consideration to Landlord entering into this Agreement: (i) Tenant hereby assigns all of Tenant's rights, title and interest to any proceeds that may be drawn by Tenant under the Letter of Credit as defined in and currently held by Existing Subtenant under the Existing Sublease (the "**Sublease L-C**"); (ii) if Tenant is entitled to draw any proceeds under the Sublease L-C (<u>i.e.</u>, in the event of the occurrence of any draw condition thereunder, including, without limitation, any default by Existing Subtenant under the Existing Sublease), Tenant shall (A) promptly notify Landlord, (B) make all commercially reasonable, diligent and good faith efforts to so draw such proceeds under the Sublease L-C (any such proceeds, "**Sublease L-C Proceeds**") and (B) deliver the Sublease L-C Proceeds to Landlord. In connection with the foregoing, Tenant hereby forever relinquishes and releases all of its right, title and interest in and to any Sublease L-C Proceeds so drawn and agrees that Landlord shall have no obligation to return any amounts thereof to Tenant (and/or offset any amounts of the Sublease L-C Proceeds through any future leasing and mitigation efforts). Further, prior to and/or concurrently with any such draw of Sublease L-C Proceeds by Tenant, Tenant hereby agrees to thereafter execute such further documents or instruments as may be necessary or appropriate to carry out the intention of the foregoing assignment of proceeds (as the case may be with respect to the timing and documentary requirements of the issuing bank). Should Tenant be unable to draw any proceeds under the Sublease L-C for any reason and/or there is not an event or occurrence of any draw condition thereunder, Tenant shall not be in violation of this provision and this Agreement will be unaffected. The foregoing obligations shall survive the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>Termination Fees for Existing Sublease</u>**. As additional consideration to Landlord for entering into this Agreement, Tenant hereby acknowledges and agrees that Tenant (or Tenant's successor) shall enter into any early termination agreement with Existing Subtenant to terminate the Existing Sublease prior to the Termination Date and to the extent such termination includes any termination fee and/or other termination consideration due and payable by Existing Subtenant to Tenant for such termination, exclusive of the Sublease L-C Proceeds ("**Sublease Early Termination Fees**"), then Landlord shall be entitled to receive an amount equal to such Sublease Early Termination Fee, which amount shall be paid by Tenant to Landlord by wire within ten (10) days after the receipt thereof from Existing Subtenant. Tenant shall provide a copy of any termination agreement to Landlord with two (2) business days of execution. The foregoing obligations shall survive the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>Consent</u>**. Provided that the agreement(s) are substantially similar to the form and content in the agreements attached as Exhibit B attached hereto and incorporated herein, Landlord expressly agrees, acknowledges, and consents to the early termination of both the Existing Sublease and Existing Sub-Sublease, the execution of the respective termination agreements on or around the date this Agreement is executed, and the Landlord further agrees, acknowledges, and consents to the date of those respective terminations being prior to the Lease Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>Brokers</u>**. Landlord and Tenant hereby represent to each other that they have had no dealings with any real estate broker or agent in connection with the negotiation of this Agreement and that they know of no real estate broker or agent who is entitled to a commission in connection with this Agreement. Each party agrees to indemnify, defend and hold the harmless the other party from any and all claims, demands, losses, liabilities, lawsuits, judgments, costs and expenses (including without limitation reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or agent occurring by, through, or under the indemnifying party. The terms of this Section 11 shall survive the Termination Date.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>Confidentiality</u>**. Tenant acknowledges that the terms and conditions of this Agreement are to remain confidential for Landlord's benefit, and may not be disclosed by Tenant to anyone, (other than on a need to know basis to Tenant's directors, officers, shareholders, advisors, consultants, financial, legal and space planning consultants) by any manner or means, directly or indirectly, without Landlord's prior written consent; however, Tenant may disclose the terms and conditions of this Agreement if required by law or court order (including, without limitation, as and to the extent required for Tenant to file a Form 8-K or any other required SEC filings). Tenant shall be liable for any disclosures made in violation of this Section by Tenant or by any entity or individual to whom the terms of and conditions of this Agreement were disclosed or made available by Tenant. The consent by Landlord to any disclosures shall not be deemed to be a waiver on the part of Landlord of any prohibition against any future disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>Attorneys' Fees</u>**. Should any dispute arise between the parties hereto or their legal representatives, successors and assigns concerning any provision of this Agreement or the rights and duties of any person in relation thereto, the party prevailing in such dispute shall be entitled, in addition to such other relief that may be granted, to recover reasonable attorneys' fees and legal costs in connection with such dispute.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>Governing Law</u>**. This Agreement shall be governed and construed under the laws of the State of California.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>Counterparts; Signatures</u>**. This Agreement may be executed in counterparts, each of which shall be deemed an original, but such counterparts, when taken together, shall constitute one agreement. Signatures of the parties transmitted by telefacsimile or electronic mail PDF format shall be deemed to constitute originals and may be relied upon, for all purposes, as binding the transmitting party hereto. The parties intend to be bound by the signatures transmitted by telefacsimile or electronic mail PDF format, are aware that the other party will rely on such signature, and hereby waive any defenses to the enforcement of the terms of this Agreement based on the form of signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>Binding Effect</u>**. This Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective legal representatives, successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>Time of the Essence</u>**. Time is of the essence of this Agreement and the provisions contained herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>Further Assurances</u>**. Landlord and Tenant hereby agree to execute such further documents or instruments as may be necessary or appropriate to carry out the intention of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>Voluntary Agreement</u>**. The parties have read this Agreement and mutual release as contained herein, and on the advice of counsel they have freely and voluntarily entered into this Agreement.

**[SIGNATURES ON FOLLOWING PAGE**]

------

IN WITNESS WHEREOF, Landlord and Tenant have executed this Agreement as of the day and year first above written.

---

| | | | |
|:---|:---|:---|:---|
| <u>**LANDLORD**</u>: | <u>**LANDLORD**</u>: | <u>**TENANT**</u>: | <u>**TENANT**</u>: |
| BAYSIDE AREA DEVELOPMENT, LLC,<br> a Delaware limited liability company | BAYSIDE AREA DEVELOPMENT, LLC,<br> a Delaware limited liability company | UNITY BIOTECHNOLOGY, INC.,<br> a Delaware corporation | UNITY BIOTECHNOLOGY, INC.,<br> a Delaware corporation |
| By: | /s/ Natalia De Michele | By: | /s/ Craig Jalbert |
| Name: | Natalia De Michele | Name: | Craig Jalbert |
| Its: | Senior Vice President | Its: | President |

---